Description
MK-3697 is a selective orexin 2 receptor antagonist.
Product Unit Size | Cost | Quantity | Stock |
---|
MK-3697 is a selective orexin 2 receptor antagonist.
Cas No. | 1224846-01-8 |
---|---|
Purity | ≥98% |
Formula | C23H21N5O3S |
Formula Wt. | 447.5 |
Chemical Name | N-[(5,6-dimethoxypyridin-2-yl)methyl]-2-(5-methylpyridin-3-yl)-5-(1,3-thiazol-2-yl)pyridine-4-carboxamide |
IUPAC Name | N-[(5,6-dimethoxypyridin-2-yl)methyl]-2-(5-methylpyridin-3-yl)-5-(1,3-thiazol-2-yl)pyridine-4-carboxamide |
Synonym | MK3697; M8238285OA; (2,3'-Bipyridine)-4-carboxamide, N-((5,6-dimethoxy-2-pyridinyl)methyl)-5'-methyl-5-(2-thiazolyl)- |
Solubility | Insoluble in water. DMSO (>20 mg/mL). |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Roecker AJ, Reger TS, Mattern MC. et.al. Discovery of MK-3697: a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia. Bioorg Med Chem Lett. (2014) 24:4884-90. PMID: 25248679 DOI: 10.1016/j.bmcl.2014.08.041.
S-isomer of omeprazole; H+/K+ ATPase inhibitor....
JAK2 inhibitor, potential EGFR inhibitor.
Juvenille insect growth hormone analog.
Impurity of omeprazole
Indole derivative found in Isatis, Calanthe, an...
4-Hydroxytamoxifen prodrug; FIASMA, SERM, PKC i...
Arginine source used to increase NO production....
Ca2+-sensing receptor agonist.
Endogenous heptapeptide; P2X3 and N-formylpepti...
Immunostimulator, adjuvant.
NO donor; AR antagonist.
PKD inhibitor.
Tretraeptide, binds cell surface integrins.
Thiazolidinedione; PPARγ agonist.
Cholesterol ester transfer protein inhibitor.
Phase II enzyme inducer; Nrf2 activator; antiox...
Taxane synthesis intermediate.
DAT inhibitor.
Pan inhibitor of ALK.